Migraine, Unspecified, Not Intractable (ICD-10-CM G43.90)
Migraine, Unspecified, Not Intractable is presented for medical audiences with practical guidance on diagnosis, escalation signals, and longitudinal care planning.
Overview
In day-to-day neurology practice, G43.90 works best when documentation captures context, trajectory, and functional impact together, and tied to practical follow-up steps for G43.90.
For YMYL reliability, ambiguity should be minimized in escalation instructions and follow-up timing, framed around the current G43.90 encounter.
Because intractable status is documented, response checkpoints and escalation thresholds should be explicit at each follow-up, and this helps keep follow-up plans safer for G43.90.
Clear communication is part of treatment quality, not an optional add-on, in a way that supports decisions for G43.90.
Symptoms
For G43.90, symptom review should capture onset speed, progression pattern, and impact on routine activities, which often changes next-visit planning for G43.90.
Pair subjective symptoms with objective findings whenever possible to reduce drift between visits, which often changes next-visit planning for G43.90.
Include caregiver observations when episodes are intermittent or awareness is reduced during events, especially useful when counseling patients about G43.90.
Ask what changed first, what changed most recently, and what the patient considers the main current limitation, especially useful when counseling patients about G43.90.
Causes
Previous episodes and prior treatment response often narrow etiology faster than broad testing alone, a detail that improves chart clarity for G43.90.
In recurrent presentations, compare the current pattern to historical baseline rather than treating each event as isolated, a practical triage signal within episodic and paroxysmal disorders (g40-g47) for G43.90.
Medication interaction, withdrawal, or dosing inconsistency should be tested against the event timeline, a detail that improves chart clarity for G43.90.
When causation is uncertain, document what evidence supports each leading option and what evidence is still missing, something that usually alters follow-up cadence in G43.90.
Diagnosis
Chart quality improves when ordered and non-ordered investigations are both explained, which often changes next-visit planning for G43.90.
Imaging, electrophysiology, sleep testing, or labs should be justified by differential priorities, not habit, something that usually alters follow-up cadence in G43.90.
A brief decision trail helps future clinicians understand why the current path was chosen, a detail that improves chart clarity for G43.90.
Begin with focused history and neurologic exam, then expand testing when results will change action, a practical triage signal within episodic and paroxysmal disorders (g40-g47) for G43.90.
Differential Diagnosis
A transparent differential note supports better handoffs across ED, inpatient, and outpatient settings, and helpful for safer handoff notes linked to G43.90.
State why key alternatives were deprioritized; this improves both safety and audit defensibility, and helpful for safer handoff notes linked to G43.90.
In evolving presentations, serial differential updates are usually safer than premature closure, a practical triage signal within episodic and paroxysmal disorders (g40-g47) for G43.90.
Ranking should be revised as data arrives to avoid anchoring on the first impression, which often changes next-visit planning for G43.90.
Prevention
Follow-up timing should match risk level, not scheduling convenience, and helpful for safer handoff notes linked to G43.90.
Written action plans outperform verbal-only guidance when symptoms recur between visits, which often changes next-visit planning for G43.90.
Prevention improves when responsibilities are explicit for patient, caregiver, and clinical team, which often changes next-visit planning for G43.90.
For this profile, prevention priority is relapse prevention with early warning recognition, a detail that improves chart clarity for G43.90.
Prognosis
Objective milestones should guide reassessment frequency and treatment adjustments, especially useful when counseling patients about G43.90.
Prognosis should be revised as new objective data emerges, not frozen at first diagnosis, which often changes next-visit planning for G43.90.
The most useful prognosis metric here is quality-of-life impact over the next 3 to 6 months, especially useful when counseling patients about G43.90.
Prognosis in G43.90 depends on etiology, baseline reserve, treatment timing, and follow-up continuity, something that usually alters follow-up cadence in G43.90.
Red Flags
Emergency criteria should be written in plain language, not only coded terminology, a practical triage signal within episodic and paroxysmal disorders (g40-g47) for G43.90.
Outpatient worsening with repeated falls, confusion, or severe headache needs expedited evaluation, a practical triage signal within episodic and paroxysmal disorders (g40-g47) for G43.90.
A thunderclap-like headache or neurologic change unlike prior episodes requires immediate emergency evaluation, which often changes next-visit planning for G43.90.
Escalate urgently for altered consciousness, new focal deficits, persistent vomiting, or rapidly progressive weakness, and helpful for safer handoff notes linked to G43.90.
Risk Factors
If recent hospitalization or medication change occurred, reassess risk before keeping prior follow-up cadence, a detail that improves chart clarity for G43.90.
Baseline cognitive status, fall risk, and caregiver availability meaningfully change outpatient safety planning, especially useful when counseling patients about G43.90.
Risk profile should include comorbidity burden, age-related vulnerability, and prior decompensation history, a detail that improves chart clarity for G43.90.
Polypharmacy and adherence barriers can shift risk more than diagnosis label alone, something that usually alters follow-up cadence in G43.90.
Treatment
At discharge, teach-back can reveal misunderstandings before they become safety events, something that usually alters follow-up cadence in G43.90.
Document what success looks like at 2 weeks, 6 weeks, and next follow-up interval, which often changes next-visit planning for G43.90.
Non-pharmacologic supports (sleep, rehabilitation, behavioral strategies, caregiver coaching) often influence outcomes substantially, which often changes next-visit planning for G43.90.
Complex cases benefit from coordinated plans across neurology, primary care, rehabilitation, and behavioral health, a detail that improves chart clarity for G43.90.
Medical References
Got questions? We’ve got answers.
Need more help? Reach out to us.
G43.90 identifies Migraine, unspecified, not intractable; documentation should align symptom pattern, clinical assessment, and plan of care. Clinical context: Migraine, Unspecified, Not Intractable within Episodic and paroxysmal disorders (G40-G47), coding variant G 43 90.
Escalate testing when symptoms worsen, progression is atypical, or early results are non-diagnostic despite ongoing concern. Reassessment decisions should be documented for Migraine, Unspecified, Not Intractable, with risk framing linked to Episodic and paroxysmal disorders (G40-G47) and coding variant G 43 90.
Prevention plans should combine trigger control, adherence support, and scheduled reassessment milestones. This care-planning guidance is tailored to Migraine, Unspecified, Not Intractable and aligned with Episodic and paroxysmal disorders (G40-G47) risk-management goals for coding variant G 43 90.
Include onset pattern, progression, objective exam findings, differential rationale, and explicit follow-up thresholds. This guidance applies to Migraine, Unspecified, Not Intractable and should be interpreted in the context of Episodic and paroxysmal disorders (G40-G47), coding variant G 43 90.
Seek urgent care for new focal deficits, severe worsening headache, persistent vomiting, confusion, seizures, or rapid functional decline. This monitoring advice is tailored to Migraine, Unspecified, Not Intractable and should be adapted to the patient's current neurologic baseline for coding variant G 43 90.

